Case 1:18-cv-01043-LPS Document 3 Filed 07/16/18 Page 1 of 4 PageID #: 132 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) NOVARTIS PHARMACEUTICALS ) CORPORATION ) ) Plaintiff, ) ) v. ) C.A. No. _____ ) ACCORD HEALTHCARE INC., INTAS ) PHARMACEUTICALS LIMITED, ) , LTD., S&B ) PHARMA, INC., AUROBINDO ) PHARMA LIMITED, AUROBINDO ) PHARMA USA, INC., ) LIMITED, BIOCON PHARMA, INC.. ) BIONPHARMA INC., BRECKENRIDGE ) PHARMACEUTICAL, INC., ) STANDARD CHEMICAL & ) PHARMACEUTICAL CO., LTD., DR. ) REDDY’S LABORATORIES, INC., DR. ) REDDY’S LABORATORIES, LTD., ) EMCURE PHARMACEUTICALS, ) HERITAGE PHARMACEUTICALS INC., ) EZRA VENTURES, LLC, FIRST TIME ) US GENERICS LLC, GLENMARK ) PHARMACEUTICALS INC., USA, ) ) LIMITED, HEC PHARM CO., LTD., HEC ) PHARM GROUP, HEC PHARM USA ) INC., HETERO USA INC, HETERO ) LABS LIMITED UNIT-V, HETERO ) LABS LIMITED, MYLAN ) PHARMACEUTICALS, INC., ) NOSTRUM LABORATORIES INC., ) NOSTRUM PHARMACEUTICALS, ) LLC, MSN LABORATORIES PRIVATE ) LIMITED, MSN PHARMACEUTICALS ) INC., PAR PHARMACEUTICAL INC., ) PRINSTON PHARMACEUTICAL INC., ) STRIDES GLOBAL PHARMA PRIVATE ) LIMITED, STRIDES PHARMA, INC., ) TORRENT PHARMA INC., TORRENT ) PHARMACEUTICALS LTD., ZYDUS ) PHARMACEUTICALS (USA) INC., and ) LIMITED ) ) Defendants.

ME1 27645531v.1 Case 1:18-cv-01043-LPS Document 3 Filed 07/16/18 Page 2 of 4 PageID #: 133

SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA)

Plaintiffs hereby provide the information below with respect to the deadlines set forth in

21 U.S.C. § 355(j):

Date Patentee(s) Received Notice: See attached chart

Date of Expiration of Patent: 9,187,405 (June 25, 2027)

Thirty Month Stay Deadline: N/A

Dated: July 16, 2018

McCARTER & ENGLISH, LLP

By: /s/ Daniel M. Silver Michael P. Kelly (#2295) OF COUNSEL: Daniel M. Silver (#4758) Benjamin A. Smyth (#5528) Jane M. Love, Ph.D. Renaissance Centre Robert Trenchard 405 N. King Street, 8th Floor Paul E. Torchia Wilmington, Delaware 19801 GIBSON, DUNN & CRUTCHER LLP (302) 984-6300 200 Park Avenue [email protected] New York, NY 10166 [email protected] (212) 351-4000 [email protected] [email protected] [email protected] Attorneys Novartis Pharmaceuticals [email protected] Corporation

Andrew P. Blythe GIBSON, DUNN & CRUTCHER LLP 333 South Grand Avenue Los Angeles, CA 90071 (213) 229-7000 [email protected]

Attorneys for Novartis Pharmaceuticals Corporation

ME1 27645531v.1 Case 1:18-cv-01043-LPS Document 3 Filed 07/16/18 Page 3 of 4 PageID #: 134

ATTACHMENT TO SUPPLEMENTAL INFORMATION FORM

Defendant(s) Date Patentee(s) Received Notice

ACCORD HEALTHCARE INC. and INTAS January 11, 2016 PHARMACEUTICALS LIMITED

ALKEM LABORATORIES, LTD. and S&B December 27, 2016 PHARMA, INC.

AUROBINDO PHARMA LIMITED and February 18, 2016 USA, INC.

BIOCON LIMITED and BIOCON April 18, 2016 PHARMA, INC.

BIONPHARMA INC. June 8, 2017

BRECKENRIDGE PHARMACEUTICAL, May 25, 2016 INC. and STANDARD CHEMICAL & PHARMACEUTICAL CO., LTD.

DR. REDDY’S LABORATORIES, INC. and April 12, 2016 DR. REDDY’S LABORATORIES, LTD.

EMCURE PHARMACEUTICALS and March 1, 2016 HERITAGE PHARMACEUTICALS INC.

EZRA VENTURES, LLC February 2, 2017

FIRST TIME US GENERICS LLC February 29, 2016

GLENMARK PHARMACEUTICALS INC., October 6, 2016 USA and GLENMARK PHARMACEUTICALS LIMITED

HEC PHARM CO., LTD., HEC PHARM January 28, 2016 GROUP, and HEC PHARM USA INC.

HETERO USA INC., HETERO LABS June 13, 2016 LIMITED UNIT-V, and HETERO LABS LIMITED

MYLAN PHARMACEUTICALS, INC. April 6, 2016

NOSTRUM LABORATORIES INC., April 7, 2016 NOSTRUM PHARMACEUTICALS, LLC,

ME1 27645541v.1 Case 1:18-cv-01043-LPS Document 3 Filed 07/16/18 Page 4 of 4 PageID #: 135

MSN LABORATORIES PRIVATE LIMITED, and MSN PHARMACEUTICALS INC.

PAR PHARMACEUTICAL INC. October 17, 2016

PRINSTON PHARMACEUTICAL INC. April 28, 2017

STRIDES GLOBAL PHARMA PRIVATE January 22, 2016 LIMITED and STRIDES PHARMA, INC.

TORRENT PHARMA INC. and TORRENT May 1, 2017 PHARMACEUTICALS LTD.

ZYDUS PHARMACEUTICALS (USA) August 19, 2016 INC. and CADILA HEALTHCARE LIMITED

ME1 27645541v.1